CapBio announced that recently, its wholly-owned subsidiary Guangzhou Kaipu Pharmaceutical Technology Co., Ltd. received a “Medical Device Production License” issued by the Guangdong Drug Administration. This change involves a change in the scope of production. The license number is Guangdong Food and Drug Control Equipment Production License No. 20173077. The production scope is Class III 6840 in vitro diagnostic reagents, which is valid until November 16, 2027.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.